India HIV Drugs Market, by Medication Class (Multi-Class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Entry Inhibitors, HIV Integrase Strand Transfer Inhibitors, Others), by Distribution Channel (Hospital Pharmacies, Drugs stores and retail pharmacies, Online pharmacies): Opportunity Analysis and Industry Forecast, 2022-2032

India hiv drugs market Analysis

The India hiv drugs market report provides market size, market share, growth rate (CAGR %) for various segments. It offers a detailed study of the market dynamics such as drivers, restraints, opportunities, and market trends. The report highlights the qualitative aspect in the market overview section of the report. In addition, the section involves the key findings and market snapshot, in terms of investment opportunities and market overview. The report also studies the competitive landscape comprising comprehensive profiles of top 10 leading players. The top players are considered on the basis of their market share, revenue size, product/service portfolio, key developments & strategies, and overall contribution to the growth of the market.

COVID-19 Impact Analysis on India hiv drugs market

The outbreak of the COVID-19 pandemic has posed major impacts across the globe; thereby, hindering the economic and social development. The report, therefore, provides a micro and macro economic analysis of the market during the pandemic. The report further offers a qualitative analysis of impact of COVID-19 on the India hiv drugs market. Additionally, the study underlines the market share and size on the basis of the overall impact of COVID-19 on the India hiv drugs market in 2020 as well as the post-impact during the subsequent years. Along with this, the report highlights the key strategies adopted by key players during the global health crisis. Moreover, it provides a detailed framework on the impact of COVID-19 on the supply chain, sales, and other major aspects of the market. Subsequently, the report also portrays the impact on the India hiv drugs market after the roll out of vaccination campaigns and other initiatives by health organizations and government bodies to curb the COVID-19 infections.

Key Inclusions

• Qualitative as well as quantitative analysis of the market on the basis of segmentation involving both economic and non-economic factors.

• Wide-ranging company profiles section, which offers different pointers including company overview, key executives, business performance, company snapshot, product/service portfolio, R&D expenditure, and key strategies & developments of the major market players.

• The existing and forecasted market outlook of the India hiv drugs market based on recent developments, which include analysis of drivers, market trends, and growth opportunities

• Impact of COVID-19 on the India hiv drugs market

• Free 20% customization and post-sales support

  India HIV Drugs Market, by Medication Class Report Highlights

Aspects	Details
By Medication Class	Protease Inhibitors (PIs) Brand Aptivus Kaletra Lexiva/ Telzir Norvir Viracept Others Entry Inhibitors Brand Selzentry Fuzeon Rukobia HIV Integrase Strand Transfer Inhibitors Brand Isentress/Isentress HD Tivicay Apretude Juluca Others Multi-Class Combination Drugs Brand Atripla Complera Prezcobix Stribild Genvoya Odefsey Symtuza Triumeq Descovy Dovato Others Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Brand Emtriva Epivir Epzicom/Kivexa Truvada Biktarvy Others Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Brand Edurant Others
By Distribution Channel	Hospital Pharmacies Drugs stores and retail pharmacies Online pharmacies

Author Name(s) : Kunal Sahu | Roshan Deshmukh

^*Terms and Conditions Apply